Dr. Christopher R. Trevino
Claim this profileTulane University Health Sciences Center
Area of expertise
Brain Tumor
Christopher R. Trevino has run 5 trials for Brain Tumor. Some of their research focus areas include:
Glioblastoma
Christopher R. Trevino has run 4 trials for Glioblastoma. Some of their research focus areas include:
Affiliated Hospitals
Tulane University Health Sciences Center
NorthShore University HealthSystem-Evanston Hospital
Clinical Trials Christopher R. Trevino is currently running
Radiation Therapy vs Observation
for Meningioma
This trial studies if radiation therapy helps prevent the return of grade II meningioma after surgery. Radiation therapy uses powerful x-rays to destroy any leftover cancer cells. The goal is to see if this improves patient outcomes compared to just monitoring them. Radiation therapy has shown success in stabilizing tumor growth and reducing recurrence risk.
Recruiting
2 awards
Phase 3
12 criteria
Relatlimab + Nivolumab
for Recurrent Glioblastoma
This phase II trial compares the safety, side effects and effectiveness of anti-lag-3 (relatlimab) and anti-PD-1 blockade (nivolumab) to standard of care lomustine for the treatment of patients with glioblastoma that has come back after a period of improvement (recurrent). Relatlimab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. A monoclonal antibody is a type of protein that can bind to certain targets in the body, such as molecules that cause the body to make an immune response (antigens). Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the tumor, and may interfere with the ability of tumor cells to grow and spread. Lomustine is a chemotherapy drug and in a class of medications called alkylating agents. It damages the cell's deoxyribonucleic acid and may kill tumor cells. Giving relatlimab and nivolumab may be safe, tolerable, and/or effective compared to standard of care lomustine in treating patients with recurrent glioblastoma.
Recruiting
1 award
Phase 2
15 criteria
More about Christopher R. Trevino
Clinical Trial Related
9 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Christopher R. Trevino has experience with
- Nivolumab
- Ipilimumab
- Lomustine
- Radiation Therapy
- Cabozantinib
- Berubicin
Breakdown of trials Christopher R. Trevino has run
Glioblastoma
Cancer
Kidney Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Christopher R. Trevino specialize in?
Christopher R. Trevino focuses on Brain Tumor and Glioblastoma. In particular, much of their work with Brain Tumor has involved MET positive patients, or patients who are MET negative.
Is Christopher R. Trevino currently recruiting for clinical trials?
Yes, Christopher R. Trevino is currently recruiting for 2 clinical trials in New Orleans Louisiana. If you're interested in participating, you should apply.
Are there any treatments that Christopher R. Trevino has studied deeply?
Yes, Christopher R. Trevino has studied treatments such as Nivolumab, Ipilimumab, Lomustine.
What is the best way to schedule an appointment with Christopher R. Trevino?
Apply for one of the trials that Christopher R. Trevino is conducting.
What is the office address of Christopher R. Trevino?
The office of Christopher R. Trevino is located at: Tulane University Health Sciences Center, New Orleans, Louisiana 70112 United States. This is the address for their practice at the Tulane University Health Sciences Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.